Takumi Kumai

Assistant Professor

Asahikawa Medical University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Takumi Kumai is an Assistant Professor at Asahikawa Medical University in Japan. His research primarily focuses on immunotherapy and its applications in head and neck cancers, as evidenced by his recent work on targets such as ROR1 and PD-1. He also investigates the comparative outcomes of various surgical approaches in oncology and the genetic underpinnings of auditory neuropathy. His contributions to the field include studies on the prognostic value of imaging and hematological parameters in cancer diagnostics.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (9)

Hideaki Takahashi

Assistant Professor

Yokohama National University

JAPAN

View details

Miki Takahara

Asahikawa Medical University

JAPAN

View details

Hiroki Komatsuda

Assistant Professor

Asahikawa Medical University

JAPAN

View details

Hisataka Ominato

Asahikawa Medical University

JAPAN

View details

Takayuki Ohkuri

JAPAN

View details

Ryosuke Sato

Asahikawa Medical University

JAPAN

View details

shuto hayashi

Cancer Institute Hospital of JFCR

JAPAN

View details

Gregory Friedman

Professor

The University of Alabama

UNITED STATES

View details

Michihisa Kono

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takumi Kumai

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

ROR1 as an Immunotherapeutic Target for Inducing Antitumor Helper T Cell Responses Against Head and Neck Squamous Cell Carcinoma

Cervical Syphilitic Lymphadenitis in Initially Suspected Malignant Disease

STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition

Comparative outcomes of video-assisted thyroidectomy and traditional open surgery: a 5-year analysis of a single center experience

Auditory Neuropathy Caused by a Structural Variation in the OTOF Gene, Identified Using Oxford Nanopore Adaptive Sampling

Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer

Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer

Prognostic Value of the 18F‐FDG PET/CT and Haematological Parameters in Head and Neck Cancer

Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD‐L1 and PD‐L2

Translational research in head and neck cancer: Molecular and immunological updates

Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases

Mitogen‐activated protein kinase inhibition augments the T cell response against <i>HOXB7</i>‐expressing tumor through human leukocyte antigen upregulation

Internal carotid artery dissection caused by elongated styloid process

The current findings in eosinophilic chronic rhinosinusitis

Thyroid metastasis from cervical carcinoma

Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study

Sensory trick in patients with opsoclonus–myoclonus syndrome

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma

The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study

Collaborators (9)

Hideaki Takahashi

Miki Takahara

Hiroki Komatsuda

Hisataka Ominato

Takayuki Ohkuri

Ryosuke Sato

shuto hayashi

Gregory Friedman

Michihisa Kono

Make your next move.